Y. Stallwood

Aggregation risk prediction for antibodies and its application to biotherapeutic development

Olga Obrezanova, Andreas Arnell, J. Zurdo, 2015, mAbs.

Neutralisation of adenovirus infectivity by ascitic fluid from ovarian cancer patients

V. Mautner, K. Fisher, Y. Stallwood, 2000, Gene Therapy.

Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies

K. Ulbrich, L. Seymour, V. Mautner, 2001, Gene Therapy.

Small Interfering RNA-Mediated Knockdown of Notch Ligands in Primary CD4+ T Cells and Dendritic Cells Enhances Cytokine Production

G. McKenzie, E. Briend, B. Champion, 2006, The Journal of Immunology.

Cellular Notch responsiveness is defined by phosphoinositide 3-kinase-dependent signals

G. McKenzie, E. Briend, B. Champion, 2006, BMC Cell Biology.

Notch: a unique therapeutic target for immunomodulation

G. McKenzie, E. Briend, B. Champion, 2005, Expert opinion on therapeutic targets.

Early Implementation of QbD in Biopharmaceutical Development: A Practical Example

Olga Obrezanova, Andreas Arnell, Thomas R. A. Gallagher, 2015, BioMed research international.